MapLight Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MPLT and other ETFs, options, and stocks.About MPLT
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP.
CEOChristopher A. Kroeger
CEOChristopher A. Kroeger
Employees—
Employees—
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2018
Founded2018
Employees—
Employees—
MPLT Key Statistics
Market cap930.15M
Market cap930.15M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume338.99K
Average volume338.99K
High today$21.38
High today$21.38
Low today$20.04
Low today$20.04
Open price$20.24
Open price$20.24
Volume179.60K
Volume179.60K
52 Week high$21.40
52 Week high$21.40
52 Week low$12.24
52 Week low$12.24
Stock Snapshot
With a market cap of 930.15M, MapLight Therapeutics(MPLT) trades at $20.70.
On 2025-12-14, MapLight Therapeutics(MPLT) stock moved within a range of $20.04 to $21.38. With shares now at $20.70, the stock is trading +3.3% above its intraday low and -3.2% below the session's peak.
Trading activity shows a volume of 179.6K, compared to an average daily volume of 338.99K.
Over the past 52 weeks, MapLight Therapeutics(MPLT) stock has traded between a high of $21.40 and a low of $12.24.
Over the past 52 weeks, MapLight Therapeutics(MPLT) stock has traded between a high of $21.40 and a low of $12.24.
People also own
Based on the portfolios of people who own MPLT. This list is generated using Robinhood data, and it’s not a recommendation.